Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on TOUAX. We currently have 0 research reports from 0 professional analysts.
|23Feb17 17:00||GNW||TOUAX : Consolidated annual revenue at €363.5 million, up by 4.4%;Improvement in the Modular Buildings business (+16.6%); 16.9% increase in sales|
|14Nov16 17:00||GNW||TOUAX : Revenue for Q3 2016|
|17Oct16 17:01||GNW||Touax Group develops its asset management activities in partnership with the Fund "Touax Investment SCA"|
|31Aug16 17:00||GNW||TOUAX : Increased consolidated revenues at €171.5 million (+2.3%); EBITDA of €21.9 million up by 44%; Positive operating income of €3.9 million ; Half-yearly net result improved by 62%|
|26Jul16 13:41||GNW||TOUAX : Success of the capital increase without preferential subscription rights and with a priority subscription period; €11.2 million raised|
|20Jul16 06:31||GNW||TOUAX launches a capital increase without preferential subscription rights with a priority subscription period for an initial amount of €9.74 million|
|12May16 17:01||GNW||TOUAX : Revenues for Q1 2016, up by 28.5% ; Sharp increase in sales revenue (+168 %) ; Positive operating income for the year 2016|
Frequency of research reports
Research reports on
20 Feb 17
Hayward Tyler Group* (HAYT): Trading update and financial position (CORP) | Petra Diamonds (PDL): Interim results (BUY) | Gemfields* (GEM): Interim results (CORP) | Premaitha Health* (NIPT): Middle East momentum (CORP) | Sound Energy (SOU): Acquisition update and TE-8 well spud (HOLD) | Proactis* (PHD): Interim trading on track (CORP) | 7digital* (7DIG): Automotive contract win (CORP)
21 Feb 17
Lighthouse Group* (LGT): Middle Britain growth (CORP) | Utilitywise* (UTW): Double-digit sales growth (CORP) | Trakm8* (TRAK): Earnings expectations cut again (CORP) | dotDigital* (DOTC): Myriad growth opportunities (CORP) | Artilium* (ARTA): Five-year Telenet deal secured and prepaid (CORP) | Netcall* (NET): Cloud investment pays off (CORP)
N+1 Singer - Small-cap quantitative research - New quality style screen + 11 quality focus stocks
09 Feb 17
We introduce our fourth and final style screen representing “quality”. This screens for stocks with the best combination of high returns on capital/equity, EBIT margins and operating cash-flow conversion rates. These criteria should help us monitor how strong underlying returns translate into share price performance over time and under varying market conditions. The screen selects the “best” 25 stocks from our universe of just over 500 stocks and, as usual, we focus on a shorter list of stocks we cover or otherwise know and believe to be particularly interesting. We provide brief investment summaries on these focus stocks on pages 4 – 9. We will monitor performance and refresh the screen in approximately 3-4 months time.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
Time to go over weight
24 Feb 17
We believe equity investors are taking an unnecessarily cautious stance on the construction sector. Forward looking indicators (e.g. consumer confidence, construction PMIs and housing starts) point to a stable market and recent sales LFL are particularly encouraging (e.g. Marshalls). Near term margins may suffer temporary distortions as inflationary pressures build. However, history has shown that modest input cost inflation is actually a positive for earnings growth in the sector. Therefore, as we move into 2018, margin trends are likely to surprise on the upside.
N+1 Singer - Morning Song 22-02-2017
22 Feb 17
CORETX (COR LN) Contract wins and new Lifestyle facility | Gooch & Housego (GHH LN) Solid Q1 trading plus earnings enhancing acquisition of StingRay Optics | NCC Group (NCC LN) Further issues in Assurance | PCI-PAL (PCIP LN) Strong H1 underpins positive outlook | UBM (UBM LN) Results | Verona Pharma (VRP LN) Phase IIa RPL554 add-on trial to tiotropium commenced